Here are the S-3 shelf registrations from SCWorx Corp. (WORX) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
An S-3 covers the shelf registration that lets an established company sell over time, so if you follow WORX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full WORX filings page.
SCWorx Corp. is registering up to 8,253,352 common shares for resale by selling stockholders: 399,860 already-issued shares and up to 7,853,492 shares issuable upon warrant exercise. Resales may occur from time to time after the registration statement becomes effective; SCWorx will receive no proceeds from those sales.
SCWorx may receive up to approximately $20.1 million in aggregate gross proceeds if all warrants are exercised for cash, for working capital and general corporate purposes; certain warrants permit cashless exercise, in which case SCWorx would receive no cash. Common shares outstanding were 1,387,099 as of October 21, 2026. The prospectus says substantial sales could depress the share price and warrant exercises will dilute existing stockholders; warrants other than the September Warrants may have adjustments that reduce exercise prices and increase shares issuable. Nasdaq's Hearings Panel granted reconsideration of its delisting decision on October 2, 2026, and trading resumed October 7 subject to conditions. SCWorx says it cannot assure compliance with Nasdaq's continued listing requirements during the Panel Monitor period or thereafter.
SCWorx Corp. is registering for resale by selling stockholders up to 13,099,253 shares of common stock. The shares include previously issued common stock and shares issuable upon warrant exercise. After the registration statement becomes effective, selling stockholders may offer shares in public or private transactions at prevailing, related, or privately negotiated prices.
SCWorx will receive no proceeds from selling-stockholder resales. It may receive up to approximately $32.5 million in aggregate gross proceeds if all warrants are exercised for cash; certain warrants may be exercised on a cashless basis, in which case the company would receive no cash. SCWorx intends to use any cash proceeds for working capital and general corporate purposes. Warrants other than the September Warrants may have exercise-price adjustments that reduce the exercise price and increase the shares issuable.
Common shares outstanding were 742,099 as of October 9, 2026. SCWorx says substantial sales could depress its share price and warrant exercises would dilute existing stockholders. Nasdaq trading resumed October 7, 2026, after the Hearings Panel granted reconsideration of a delisting decision, subject to panel conditions; SCWorx says it cannot assure continued compliance with Nasdaq’s continued listing requirements during the Panel Monitor period or thereafter.